ArticleMolecular therapy : the journal of the American Society of Gene Therapy2014

A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responses.

James M Markert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.